ASX:OPL

Opyl (OPL) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
10.83%
Price Target
N/A
OPL stock logo

About Opyl Stock (ASX:OPL)

Opyl Limited develops digital tools that enhance healthcare experience for patients in Australia. The company also delivers deep market insights from social media data and enhance clinical research process. It offers Opin, a clinical trial recruitment platform that leverages social media, search engine optimization technologies and emerging artificial intelligence science, and matching patients directly to clinical trials. The company was formerly known as ShareRoot Limited and changed its name to Opyl Limited in December 2019. Opyl Limited was incorporated in 1994 and is based in St Kilda, Australia.

OPL Stock News Headlines

See More Headlines
Receive OPL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Opyl and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-2,380,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$902,413.00

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
2.11
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Mark Ziirsen (Age 61)
    CFO & Executive Chairman
    Comp: $93.92k
  • Mr. Damon Rasheed
    CTO & Executive Director
  • Mr. Saurabh Jain
    Interim CEO
  • Mr. Shane Lewis
    Vice President of Sales & Partnerships
  • Mr. Scott Sorochak
    Chief Revenue Officer
  • Mr. David Lilja M.B.A.
    Company Secretary

This page (ASX:OPL) was last updated on 5/15/2024 by MarketBeat.com Staff

From Our Partners